Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62.5M
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
26K
-
Shares change
-
-64.2M
-
Total reported value, excl. options
-
$2.57M
-
Value change
-
-$8.23B
-
Number of sells
-
-336
-
Price
-
$128.44
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q3 2025
363 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q3 2025.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26K shares
of 62.5M outstanding shares and own 0.04% of the company stock.
Largest 10 shareholders include DekaBank Deutsche Girozentrale (25.9K shares), VAN ECK ASSOCIATES CORP (132 shares), OSAIC HOLDINGS, INC. (23 shares), HUNTINGTON NATIONAL BANK (1 shares), Farther Finance Advisors, LLC (0 shares), HIGHLINE WEALTH PARTNERS LLC (0 shares), Rise Advisors, LLC (0 shares), Private Wealth Management Group, LLC (0 shares), AdvisorNet Financial, Inc (0 shares), and Trium Capital LLP (0 shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.